We will continue to investigate the molecular mechanisms of NSCLC-induced immune tolerogenic CD1c+ DC subsets mediated by CD103 and CD205 in the future so that the cellular mechanisms of NSCLC-mediated immune suppressive micro-environment can be further elucidated. The gene discussed is CD1C; the disease is non-small cell lung carcinoma.